Arrowhead Pharmaceuticals (ARWR) Q3 2025 Earnings

Aug 7Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.39
-0.01
1.37
2.75

Details

Expected EPS
-0.952272
Actual EPS
-1.26
Surprise EPS
-0.31
Surprise Percent
-32.32%

Description

⁨Arrowhead Pharmaceuticals⁩ (⁦ARWR⁩) has reported earnings of ⁦-1.26⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts